US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 8.620
- +0.330+3.98%
Close Dec 13 16:00 ET
168.36MMarket Cap-5.92P/E (TTM)
8.680High7.620Low33.93KVolume8.070Open8.290Pre Close281.02KTurnover1.21%Turnover RatioLossP/E (Static)19.53MShares10.16252wk High31.46P/B24.14MFloat Cap5.51052wk Low--Dividend TTM2.80MShs Float10.162Historical High--Div YieldTTM12.79%Amplitude5.510Historical Low8.281Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Actuate Therapeutics Stock Forum
CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted b...
No comment yet